Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LQDA
|
Sarah Krepp
Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct | 13,165 Reduced 8.55% |
$492,765
$37.43 p/Share
|
Jan 12
2026 |
|
LQDA
|
Rajeev Saggar
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 21,142 Reduced 10.68% |
$791,345
$37.43 p/Share
|
Jan 12
2026 |
|
LQDA
|
Dana Boyle
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 11,047 Reduced 6.59% |
$413,489
$37.43 p/Share
|
Jan 12
2026 |
|
LQDA
|
Roger Jeffs
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 66,610 Reduced 6.03% |
$2,493,212
$37.43 p/Share
|
Jan 12
2026 |
|
URBN
|
Margaret Hayne
Co-President & CCO |
SELL
Open market or private sale
|
Indirect | 9,333 Reduced 0.0% |
$696,335
$74.61 p/Share
|
Jan 12
2026 |
|
LQDA
|
Russell Schundler
General Counsel |
SELL
Open market or private sale
|
Direct | 27,289 Reduced 4.5% |
$1,021,427
$37.43 p/Share
|
Jan 12
2026 |
|
LQDA
|
Jason Adair
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 13,548 Reduced 6.85% |
$507,101
$37.43 p/Share
|
Jan 12
2026 |
|
URBN
|
Richard A Hayne
CEO & Chairman of the Board |
SELL
Open market or private sale
|
Direct | 10,667 Reduced 0.06% |
$795,864
$74.61 p/Share
|
Jan 12
2026 |
|
URBN
|
Richard A Hayne
CEO & Chairman of the Board |
SELL
Open market or private sale
|
Indirect | 9,333 Reduced 0.0% |
$696,335
$74.61 p/Share
|
Jan 12
2026 |
|
IRMD
|
Roger E. Susi
CEO, PRESIDENT, CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$488,950
$97.79 p/Share
|
Jan 12
2026 |
|
ACVA
|
George Chamoun
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 14,286 Added 0.55% |
$125,859
$8.81 p/Share
|
Jan 12
2026 |
|
BRKR
|
Mark Munch
EXEC VP&PRES BRUKER NANO INC. |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 5.17% |
$385,000
$55.0 p/Share
|
Jan 12
2026 |
|
CNXA
|
Hongyu Zhou
Director |
BUY
Open market or private purchase
|
Direct | 744,496 Added 31.73% |
$1,049,739
$1.41 p/Share
|
Jan 12
2026 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,122,615
$146.46 p/Share
|
Jan 12
2026 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,122,615
$146.46 p/Share
|
Jan 12
2026 |
|
RDW
|
Ae Red Holdings, LLC
Director |
SELL
Open market or private sale
|
Indirect | 2,871,715 Reduced 0.0% |
$30,928,370
$10.77 p/Share
|
Jan 12
2026 |
|
RKT
|
Matthew Rizik
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.24% |
$57,474
$22.99 p/Share
|
Jan 12
2026 |
|
INSM
|
William Lewis
Chair and CEO |
SELL
Open market or private sale
|
Direct | 19,215 Reduced 5.89% |
$3,279,424
$170.67 p/Share
|
Jan 12
2026 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$311
$311.84 p/Share
|
Jan 12
2026 |
|
MCD
|
Joseph M. Erlinger
President, McDonald's USA |
SELL
Open market or private sale
|
Direct | 2,626 Reduced 32.73% |
$805,079
$306.58 p/Share
|
Jan 12
2026 |
|
AIR
|
John Mc Clain Holmes Iii
Chairman, President & CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 11.23% |
$2,925,000
$97.5 p/Share
|
Jan 12
2026 |
|
MEGI
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,586 Reduced 0.0% |
$419,639
$13.72 p/Share
|
Jan 12
2026 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 9,508 Added 0.0% |
$610,318
$64.19 p/Share
|
Jan 12
2026 |
|
IIF
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,884 Reduced 0.0% |
$243,146
$24.6 p/Share
|
Jan 12
2026 |
|
GF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 905 Added 0.0% |
$10,932
$12.08 p/Share
|
Jan 12
2026 |
|
MXF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,520 Added 0.0% |
$51,534
$20.45 p/Share
|
Jan 12
2026 |
|
TPVG
|
Sajal Srivastava
President and CIO |
BUY
Open market or private purchase
|
Indirect | 23,799 Added 0.0% |
$158,501
$6.66 p/Share
|
Jan 12
2026 |
|
TPVG
|
James Labe
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 23,799 Added 0.0% |
$158,501
$6.66 p/Share
|
Jan 12
2026 |
|
BUKS
|
Michael Anthony Loh
Director |
BUY
Open market or private purchase
|
Direct | 8,000 Added 5.62% |
$22,960
$2.87 p/Share
|
Jan 12
2026 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 774 Added 0.0% |
$2,020
$2.61 p/Share
|
Jan 12
2026 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 360 Added 0.26% |
$939
$2.61 p/Share
|
Jan 12
2026 |
|
COSM
|
Grigorios Siokas
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 113,185 Added 1.54% |
$56,592
$0.5 p/Share
|
Jan 12
2026 |
|
ZKP
|
Samuel A. Iv Jernigan
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 435,000 Added 0.0% |
-
|
Jan 12
2026 |
|
ZKP
|
Lafayette Digital Sponsor I, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 435,000 Added 50.0% |
-
|
Jan 12
2026 |
|
ACLX
|
Christopher Heery
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 6,131 Reduced 14.19% |
$393,303
$64.15 p/Share
|
Jan 12
2026 |
|
LIND
|
Benjamin Bressler
*Founder & CEO of NHA |
SELL
Open market or private sale
|
Direct | 222,386 Reduced 90.46% |
$3,575,966
$16.08 p/Share
|
Jan 12
2026 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,224 Added 0.0% |
$11,322
$9.25 p/Share
|
Jan 12
2026 |
|
ZYME
|
Jeffrey T L Smith
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 9,310 Reduced 25.85% |
$211,057
$22.67 p/Share
|
Jan 12
2026 |
|
ZYME
|
Paul Andrew Moore
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 9,560 Reduced 16.47% |
$216,725
$22.67 p/Share
|
Jan 12
2026 |
|
AKTS
|
Eco R1 Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 2,222,222 Added 0.0% |
$39,999,996
$18.0 p/Share
|
Jan 12
2026 |
|
KTOS
|
Stacey G Rock
President, KTT Division |
SELL
Open market or private sale
|
Direct | 16,568 Reduced 38.48% |
$1,940,775
$117.14 p/Share
|
Jan 12
2026 |
|
ZYME
|
Kenneth Galbraith
Chair & CEO |
SELL
Open market or private sale
|
Direct | 30,424 Reduced 11.83% |
$689,712
$22.67 p/Share
|
Jan 12
2026 |
|
NTSK
|
Raphael Bousquet
Chief Revenue Offucer |
SELL
Open market or private sale
|
Direct | 3,823 Reduced 100.0% |
$63,691
$16.66 p/Share
|
Jan 12
2026 |
|
ABOS
|
Daniel Joseph O Connell
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,388 Reduced 0.9% |
$9,321
$1.73 p/Share
|
Jan 12
2026 |
|
ABOS
|
Derek M Meisner
Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct | 8,548 Reduced 9.26% |
$14,617
$1.71 p/Share
|
Jan 12
2026 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.16% |
$747,450
$16.61 p/Share
|
Jan 12
2026 |
|
PTCT
|
Eric Pauwels
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 1,024 Reduced 1.26% |
$80,588
$78.7 p/Share
|
Jan 12
2026 |
|
AKTS
|
Vida Ventures Ii, LLC |
BUY
Open market or private purchase
|
Indirect | 835,000 Added 0.0% |
$15,030,000
$18.0 p/Share
|
Jan 12
2026 |
|
HOWL
|
Luke Evnin |
SELL
Open market or private sale
|
Indirect | 58,980 Reduced 0.0% |
$33,618
$0.57 p/Share
|
Jan 12
2026 |
|
AKTS
|
Helen Susan Kim |
BUY
Open market or private purchase
|
Indirect | 835,000 Added 0.0% |
$15,030,000
$18.0 p/Share
|
Jan 12
2026 |